Terug
Dagbereik
€ 31,72
€ 34,16
52-Weeksbereik
€ 31,71
€ 90,32
Volume
951.302
50D / 200D Gem.
€ 39,76
/
€ 59,33
Vorige Slotkoers
€ 33,22
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 81,6 | 0,4 |
| P/B | 3,8 | 2,9 |
| ROE % | 6,0 | 3,8 |
| Net Margin % | 11,0 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 101,20
+219.0%
Low: € 60,00
High: € 125,00
Forward K/W
8,2
Forward WPA
€ 3,89
WPA Groei (sch.)
+0,0%
Omzet Sch.
470 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 16,04
€ 14,31 – € 18,79
|
1,6 B | 5 |
| FY2029 |
€ 12,81
€ 11,43 – € 15,01
|
1,4 B | 2 |
| FY2028 |
€ 9,18
€ 4,72 – € 13,23
|
1 B | 7 |
Belangrijkste Punten
Debt/Equity of 0,01 — conservative balance sheet
Generating 46,73M in free cash flow
P/E of 81,55 — premium valuation
Cash machine — converts 223,67% of earnings into free cash flow
Capital efficient — spends only 0,04% of revenue on capex
ROIC of 2,48% — low return on invested capital
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
6,01%
ROIC2,48%
Net Margin10,97%
Op. Margin7,85%
Veiligheid
Debt / Equity
0,01
Current Ratio5,80
Interest Coverage2,73
Waardering
P/E Ratio
81,55
P/B Ratio3,78
EV/EBITDA109,45
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 190,41M | Net Income (TTM) | 20,89M |
| ROE | 6,01% | ROA | 3,71% |
| Gross Margin | 98,58% | Operating Margin | 7,85% |
| Net Margin | 10,97% | Free Cash Flow (TTM) | 46,73M |
| ROIC | 2,48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,80 |
| Interest Coverage | 2,73 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 81,55 | P/B Ratio | 3,78 |
| P/S Ratio | 8,95 | PEG Ratio | -1,08 |
| EV/EBITDA | 109,45 | Dividend Yield | 0,00% |
| Market Cap | 1,70B | Enterprise Value | 1,64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 190,41M | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | 20,89M | -175,85M | -38,99M | -24,07M | -30,91M |
| EPS (Diluted) | 0,39 | -4,38 | -2,36 | -2,87 | -5,81 |
| Gross Profit | 187,71M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | 14,95M | -187,67M | -41,38M | -24,40M | -31,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 563,83M | 330,97M | 180,69M | 26,50M | 35,55M |
| Total Liabilities | 113,72M | 85,86M | 23,18M | 16,15M | 17,76M |
| Shareholders' Equity | 450,12M | 245,11M | 157,51M | 10,35M | 17,79M |
| Total Debt | 2,69M | 52,83M | 403.000,0 | 155.000,0 | 457.000,0 |
| Cash & Equivalents | 70,11M | 87,93M | 169,68M | 14,60M | 21,30M |
| Current Assets | 355,81M | 293,89M | 171,36M | 15,65M | 22,42M |
| Current Liabilities | 61,36M | 18,75M | 11,51M | 7,31M | 8,01M |